Capsulotomy triggers prostaglandin release in FLACS

Article

Anterior capsulotomy triggers an increase of prostaglandins in the aqueous humour immediately after FLACS, according to researchers from Ruhr University Eye Hospital, Bochum, Germany.

Anterior capsulotomy is the main trigger for an increase of prostaglandins in the aqueous humour that occurs immediately after femtosecond laser-assisted cataract surgery (FLACS), according to researchers from the Institute for Vision Science and the Experimental Eye Research Institute, Ruhr University Eye Hospital, Bochum, Germany.

Reporting in the Journal of Refractive Surgery, the researchers collected the aqueous humour from 67 patients twice: once after the pretreatment for FLACS (only capsulotomy, only fragmentation, or both) and again at the beginning of routine cataract surgery. They then used an enzyme-linked immunoassay to measure total prostaglandin levels in all four groups.

Significantly higher levels of aqueous humour prostaglandins were detected immediately after the procedure in patients who underwent both capsulotomy and fragmentation (330.6 ± 110.6 pg/mL) or only laser capsulotomy 362.4 ± 117.5 pg/mL), compared to the control group (52.5 ± 8.1 pg/mL).

Patients who underwent only FLACS fragmentation did not demonstrate a prostaglandin increase (186.8 ± 114.0 pg/mL).

The researcher concluded that it may be possible to reduce laser-induced miosis by optimizing the laser’s energy settings and using nonsteroidal anti-inflammatory drugs.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.